Hemptation Infused Goods scores points for innovation thanks to its unusual CBD oil-infused honey, which is harvested from hives in Vermont and, according to the company, has a “slightly spicy bite.” That said, customers who prefer not to get their CBD hit on toast may instead opt for one of Hemptation’s similarly novel bath bombs, designed to either invigorate or help unwind when the user settles in for a soak. More traditional types might be relieved to hear, however, that the company also offers sublingual CBD oils in dropper bottles, 99-percent pure slabs of CBD isolate and wax – the latter made from a whole extract of the hemp plant. Furthermore, Hemptation arguably takes customer service to the next level by offering in-person consultations about CBD, available to those living in Massachusetts or Vermont for a $60 fee. Anyone further afield, meanwhile, can take advantage of a similar but more inexpensive service by either telephone or live chat online.
The benefits of CBD for anxiety have traditionally been assessed through subjective reports, like anxiety questionnaires and surveys, but recent groundbreaking research has been able to demonstrate that CBD upregulates specific neurotransmitter pathways in the brain, and changes cerebral blood flow patterns to areas of the brain linked to the symptoms of anxiety. These mechanistic changes make an even stronger case that CBD is an effective way to reduce feelings of anxiety.
The endocannabinoid system is spread throughout your brain and body, but primarily throughout your central nervous system. The interaction between cannabinoids and receptors is what produces effects like the regulation of mood, pain, appetite, inflammation, and memory. Plant-based cannabinoids, found in cannabis plants, also interact with the receptors (whimsically named CB1 and CB2) in the endocannabinoid system, and each affects your body in different ways. CBD and its infamous cousin THC are the 2 most well-known cannabinoids.
Generalized pain, for instance, has dozens upon dozens of high profile research and clinical studies that have been carried out in universities and laboratories around the globe. One of the most well-publicized of these studies took place back in 2008, in which results determined that “cannabinoid analgesics (pain relievers) have generally been well tolerated in clinical trials … with acceptable adverse event profiles (meaning acceptable effectiveness for practical use).